We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.26%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$3.42B
AUM Growth
-$3.55B
(-51%)
Cap. Flow
-$6.15B
Cap. Flow
% of AUM
-179.9%
Top 10 Holdings %
Top 10 Hldgs %
20.13%
Holding
4,628
New
1,022
Increased
432
Reduced
2,408
Closed
560
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
+$122M |
| 2 |
Vanguard Value ETF
VTV
|
+$91.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$58.4M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$56.3M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
+$52.1M |
Top Sells
Sector Composition
| 1 | Technology | 9.32% |
| 2 | Financials | 5.1% |
| 3 | Healthcare | 4.19% |
| 4 | Consumer Discretionary | 3.06% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Idaho Strategic Resources
IDR
$469M
| $403 | ﹤0.01% |
10
-34
| -77% | -$1.3K |
|
3627
VanEck Long Muni ETF
MLN
$694M
| $403 | ﹤0.01% |
23
| – | – |
|
3628
Virginia National Bankshares
VABK
$242M
| $399 | ﹤0.01% |
10
-361
| -97% | -$14.4K |
|
3629
Boston Beer
SAM
$1.82B
| $391 | ﹤0.01% |
2
-9,890
| -100% | -$2.04M |
|
3630
Zumiez
ZUMZ
$312M
| $391 | ﹤0.01% |
15
-3,679
| -100% | -$88.4K |
|
3631
Intuitive Machines
LUNR
$2.55B
| $390 | ﹤0.01% |
24
-271
| -92% | -$3.14K |
|
3632
Phreesia
PHR
$686M
| $390 | ﹤0.01% |
23
-1,947
| -99% | -$40.2K |
|
3633
AnaptysBio
ANAB
$2B
| $388 | ﹤0.01% |
+8
| New | +$312 |
|
3634
Ituran Location and Control
ITRN
$1.11B
| $387 | ﹤0.01% |
+9
| New | +$353 |
|
3635
Braze
BRZE
$2.98B
| $377 | ﹤0.01% |
11
-4,138
| -100% | -$123K |
|
3636
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.41B
| $372 | ﹤0.01% |
17
| – | – |
|
3637
Globalstar
GSAT
$10.4B
| $366 | ﹤0.01% |
6
-647
| -99% | -$35.7K |
|
3638
Stratus Properties
STRS
$167M
| $363 | ﹤0.01% |
15
-13
| -46% | -$273 |
|
3639
BioCryst Pharmaceuticals
BCRX
$2.55B
| $359 | ﹤0.01% |
46
-2,947
| -98% | -$21.3K |
|
3640
Editas Medicine
EDIT
$473M
| $359 | ﹤0.01% |
175
-6,354
| -97% | -$18.3K |
|
3641
City Holding Co
CHCO
$1.87B
| $358 | ﹤0.01% |
3
-352
| -99% | -$42.8K |
|
3642
Xometry
XMTR
$5.32B
| $357 | ﹤0.01% |
6
-150
| -96% | -$8.46K |
|
3643
Byrna Technologies
BYRN
$88.7M
| $353 | ﹤0.01% |
21
+15
| +250% | +$292 |
|
3644
Dyne Therapeutics
DYN
$3.85B
| $352 | ﹤0.01% |
18
-465
| -96% | -$8.81K |
|
|
XXI
3645
Twenty One Capital Inc
XXI
$1.8B
| $351 | ﹤0.01% |
+40
| New | +$418 |
|
3646
First Financial Bancorp
FFBC
$3.6B
| $350 | ﹤0.01% |
14
-2,856
| -100% | -$71.3K |
|
3647
Acadia Healthcare
ACHC
$2.91B
| $341 | ﹤0.01% |
+24
| New | +$454 |
|
3648
Tanger
SKT
$4.56B
| $334 | ﹤0.01% |
10
-17
| -63% | -$567 |
|
3649
New Oriental
EDU
$7.78B
| $330 | ﹤0.01% |
+6
| New | +$329 |
|
3650
UroGen Pharma
URGN
$1.86B
| $328 | ﹤0.01% |
14
-12,365
| -100% | -$268K |
|
Similar funds
AC
TYCC
PL
VA
TH
RSWM
ACA
AL